alexa Extracellular Vesicles As Novel Biomarkers In Translational Medicine
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference on Translational Medicine
November 03-05, 2014 Las Vegas, USA

Winston Patrick Kuo
Accepted Abstracts: Transl Med
DOI: 10.4172/2161-1025.S1.014
Abstract
Extracellular vesicles (EVs), including exosomes and microvesicles, have emerged as a promising minimally invasive novel source of material for molecular diagnostics. Within the past 5 years, it has been shown that EVs carry a variety of biomacromolecules including mRNA, microRNA (miRNA) and other non-coding RNAs, providing an incentive to focus research and development efforts on the potential clinical utility of EVs for the purpose of disease detection and monitoring therapeutic responses. EVs are multifunctional entities that appear to play an active role in many significant biological processes, such as regulation of immune response, antigen presentation, transfer of bioactive molecules between cells and tissues, and transfer of viruses and prions. Innovative and more efficient means of nucleic acid profiling are needed to facilitate investigations into the cellular and molecular mechanisms of EV function, and to establish their potential as useful clinical biomarkers and potential therapeutic tools. Although EVs can be easily identified and collected from biological fluids, further research and proper validation is needed in order for them to be useful in the clinical setting. Research on tumor-derived EVs from prostate cancer and its clinical utility will be presented.
Biography
Winston Patrick Kuo is currently on the Scientific Advisory Board of Exosomics, Siena, Italy and HansaBioMed, Tallin, Estonia, both exosome-based commercial entities, the former focused on clinical diagnostics and the later, life science products. He is also Editor in Chief of the journal, Exosomes and Microvesicles and former consultant for Exosome Diagnostics. He was Assistant Professor in the Department of Developmental Biology at Harvard School of Dental Medicine and Director and Founder of the Harvard Clinical and Translational Science ? Laboratory for Innovative Translational Technologies at Harvard Medical School. He received his DDS from Columbia University and received his DMSc in Oral Biology, with a focus on computational biology from Harvard University and his SM in Medical Informatics from the Massachusetts Institute of Technology, Division of Health Sciences and Technology.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords